Loading clinical trials...
Loading clinical trials...
Open Label, Single Arm Clinical Trial to Evaluate the Safety and Efficacy of CT0594CP in Patients With Relapsed and/or Refractory Multiple Myeloma or Plasma Cell Leukemia
Conditions
Interventions
Biological
Locations
1
China
Shanghai Tongji Hospital
Shanghai, Shanghai Municipality, China
Start Date
April 12, 2023
Primary Completion Date
January 1, 2026
Completion Date
January 1, 2026
Last Updated
June 8, 2023
NCT03715478
NCT03416374
NCT05297240
Lead Sponsor
Aibin Liang，MD，Ph.D.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions